{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:49:58Z","timestamp":1791838198125,"version":"4.3.4"},"reference-count":79,"publisher":"Termedia Sp. z.o.o.","issue":"1","license":[{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cent Eur J Immunol"],"abstract":"<jats:p>Eosinophilia is a feature of multiple conditions, both hematologic and non-hematologic, and may be associated with organ damage. The pathogenesis of eosinophilia can follow two distinct pathways. Primary eosinophilia is caused by a cell-intrinsic mechanism originating from clonal expansion of eosinophils through acquisition of a somatic mutation, such as FIP1L1-PDGFRA. In recent years, great progress has been made in the field of pathogenesis and molecularly targeted therapy of neoplastic eosinophilia. The diagnostic procedure should include, among other things, morphologic analysis of blood and bone marrow samples, cytogenetics and fluorescence in situ-hybridization tests to detect evidence of an acute or chronic myeloid or lymphoid disorder. Secondary eosinophilia follows a cell-extrinsic mechanism as a response to exogenous cytokines. In most clinical cases, peripheral blood eosinophilia is reactive and typically associated with non-hematological disorders such as infections, allergic conditions, connective tissue disorders, vasculitis, malignancy, or endocrinopathies. Nonetheless, the cause of most cases of hypereosinophilic syndrome remains unknown. In this article, we present a short review focused on differential diagnosis of eosinophilia and eosinophilic disorders. The diagnosis of eosinophilia is a challenge for physicians; thus this review may be useful in clinical practice.<\/jats:p>","DOI":"10.5114\/ceji.2024.136512","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T09:30:28Z","timestamp":1714383028000},"page":"60-69","source":"Crossref","is-referenced-by-count":10,"title":["The challenge of diagnosing and classifying eosinophilia and eosinophil disorders: A review"],"prefix":"10.5114","volume":"49","author":[{"given":"Agnieszka","family":"Szymczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Jaworski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Podhorecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3061","published-online":{"date-parts":[[2024,4,19]]},"reference":[{"key":"ref-1535855","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.blre.2009.01.001","article-title":"Pathogenesis, classification, and therapy of Eosinophilia and Eosinophil disorders","volume":"23","author":"Valent P","year":"2009","unstructured":"Valent P (2009): Pathogenesis, classification, and therapy of Eosinophilia and Eosinophil disorders. Blood Rev 23: 157-165.","journal-title":"Blood Rev"},{"key":"ref-1535856","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1067\/mai.2000.105712","article-title":"Mechanisms of Eosinophil-associated inflammation","volume":"105","author":"Gleich GJ","year":"2000","unstructured":"Gleich GJ (2000): Mechanisms of Eosinophil-associated inflammation. J Allergy Clin Immunol 105: 651-663.","journal-title":"J Allergy Clin Immunol"},{"key":"ref-1535857","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/ehm.11.81","article-title":"Pathogenesis and classification of eosinophil disorders: A review of recent developments in the field","volume":"5","author":"Valent P","year":"2012","unstructured":"Valent P, Gleich GJ, Reiter A, et al. (2012): Pathogenesis and classification of eosinophil disorders: A review of recent developments in the field. Expert Rev Hematol 5: 157-176.","journal-title":"Expert Rev Hematol"},{"key":"ref-1535858","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.iac.2015.04.004","article-title":"Eosinophilia in hematologic disorders","volume":"35","author":"Falchi L","year":"2015","unstructured":"Falchi L, Verstovsek S (2015): Eosinophilia in hematologic disorders. Immunol Allergy Clin North Am 35: 439-452.","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref-1535859","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ajh.23664","article-title":"World Health Organization-defined Eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management","volume":"89","author":"Gotlib J","year":"2014","unstructured":"Gotlib J (2014): World Health Organization-defined Eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management. Am J Hematol 89: 325-337.","journal-title":"Am J Hematol"},{"key":"ref-1535860","first-page":"963","article-title":"Eosinophilia detected by automated blood cell counting in ambulatory North American outpatients. Incidence and clinical significance","volume":"121","author":"Brigden M","year":"1997","unstructured":"Brigden M, Graydon C (1997): Eosinophilia detected by automated blood cell counting in ambulatory North American outpatients. Incidence and clinical significance. Arch Pathol Lab Med 121: 963-967.","journal-title":"Arch Pathol Lab Med"},{"key":"ref-1535861","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2141.2006.06038.x","article-title":"Eosinophilia: Secondary, clonal and idiopathic","volume":"133","author":"Tefferi A","year":"2006","unstructured":"Tefferi A, Patnaik MM, Pardanani A (2006): Eosinophilia: Secondary, clonal and idiopathic. Br J Haematol 133: 468-492.","journal-title":"Br J Haematol"},{"key":"ref-1535862","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of Eosinophilic disorders and related syndromes","volume":"130","author":"Valent P","year":"2012","unstructured":"Valent P, Klion AD, Horny HP, et al. (2012): Contemporary consensus proposal on criteria and classification of Eosinophilic disorders and related syndromes. J Allergy Clin Immunol 130: 607-612.e9.","journal-title":"J Allergy Clin Immunol"},{"key":"ref-1535863","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ajh.24880","article-title":"World Health Organization-defined Eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management","volume":"92","author":"Gotlib J","year":"2017","unstructured":"Gotlib J (2017): World Health Organization-defined Eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management. Am J Hematol 92: 1243-1259.","journal-title":"Am J Hematol"},{"key":"ref-1535864","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2141.2003.04195.x","article-title":"The Eosinophilias, including the idiopathic hypereosinophilic syndrome","volume":"121","author":"Brito-Babapulle F","year":"2003","unstructured":"Brito-Babapulle F (2003): The Eosinophilias, including the idiopathic hypereosinophilic syndrome. Br J Haematol 121: 203-223.","journal-title":"Br J Haematol"},{"key":"ref-1535865","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ajh.22062","article-title":"World Health Organization-defined Eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management","volume":"86","author":"Gotlib J","year":"2011","unstructured":"Gotlib J (2011): World Health Organization-defined Eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management. Am J Hematol 86: 677-688.","journal-title":"Am J Hematol"},{"key":"ref-1535866","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.MCHD-0032-2016"},{"key":"ref-1535867","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ai.2018.03.001","article-title":"Eosinophil development, disease involvement, and therapeutic suppression","volume":"138","author":"Fulkerson PC","year":"2018","unstructured":"Fulkerson PC, Rothenberg ME (2018): Eosinophil development, disease involvement, and therapeutic suppression. Adv Immunol 138: 1-34.","journal-title":"Adv Immunol"},{"key":"ref-1535868","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1084\/jem.20081756","article-title":"Identification of the human eosinophil lineage-committed progenitor: Revision of phenotypic definition of the human common myeloid progenitor","volume":"206","author":"Mori Y","year":"2009","unstructured":"Mori Y, Iwasaki H, Kohno K, et al. (2009): Identification of the human eosinophil lineage-committed progenitor: Revision of phenotypic definition of the human common myeloid progenitor. J Exp Med 206: 183-193.","journal-title":"J Exp Med"},{"key":"ref-1535869","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1067\/mai.2003.1382","article-title":"Anti-IL-5 (Mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics","volume":"111","author":"Menzies-Gow A","year":"2003","unstructured":"Menzies-Gow A, Flood-Page P, Sehmi R, et al. (2003): Anti-IL-5 (Mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol 111: 714-719.","journal-title":"J Allergy Clin Immunol"},{"key":"ref-1535870","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/all.12861","article-title":"IL-33 mediates reactive Eosinophilopoiesis in response to airborne allergen exposure","volume":"71","author":"Anderson EL","year":"2016","unstructured":"Anderson EL, Kobayashi T, Iijima K, et al. (2016): IL-33 mediates reactive Eosinophilopoiesis in response to airborne allergen exposure. Allergy 71: 977-988.","journal-title":"Allergy"},{"key":"ref-1535871","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.jaci.2007.02.010","article-title":"Eosinophilic disorders","volume":"119","author":"Simon D","year":"2007","unstructured":"Simon D, Simon HU (2007): Eosinophilic disorders. J Allergy Clin Immunol 119: 1291-1300.","journal-title":"J Allergy Clin Immunol"},{"key":"ref-1535872","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.iac.2015.05.002","article-title":"Eosinophilia in pulmonary disorders","volume":"35","author":"Woolnough K","year":"2015","unstructured":"Woolnough K, Wardlaw AJ (2015): Eosinophilia in pulmonary disorders. Immunol Allergy Clin North Am 35: 477-492.","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref-1535873","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2147\/COPD.S115969","article-title":"Evidence of eosinophil extracellular trap cell death in COPD: Does it represent the trigger that switches on the disease?","volume":"12","author":"Uribe Echevarr\u00eda L","year":"2017","unstructured":"Uribe Echevarr\u00eda L, Leimgruber C, Garc\u00eda Gonz\u00e1lez J, et al. (2017): Evidence of eosinophil extracellular trap cell death in COPD: Does it represent the trigger that switches on the disease? Int J Chron Obstruct Pulmon Dis 12: 885-896.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref-1535874","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12016-015-8506-7","article-title":"Hypereosinophilic syndrome","volume":"50","author":"Curtis C","year":"2016","unstructured":"Curtis C, Ogbogu P (2016): Hypereosinophilic syndrome. Clin Rev Allergy Immunol 50: 240-251.","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref-1535875","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.anai.2018.05.014","article-title":"Hypereosinophilic syndrome in the differential diagnosis of pulmonary infiltrates with eosinophilia","volume":"121","author":"Zimmermann N","year":"2018","unstructured":"Zimmermann N, Wikenheiser-Brokamp KA (2018): Hypereosinophilic syndrome in the differential diagnosis of pulmonary infiltrates with eosinophilia. Ann Allergy Asthma Immunol 121: 179-185.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref-1535876","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12328-016-0661-8","article-title":"Idiopathic hypereosinophilic syndrome presenting with hepatitis and achalasia","volume":"9","author":"Cheung AC","year":"2016","unstructured":"Cheung AC, Hachem CY, Lai J (2016): Idiopathic hypereosinophilic syndrome presenting with hepatitis and achalasia. Clin J Gastroenterol 9: 238-242.","journal-title":"Clin J Gastroenterol"},{"key":"ref-1535877","first-page":"53","article-title":"Current concepts on the pathogenesis of the hypereosinophilic syndrome\/chronic eosinophilic leukemia","volume":"1","author":"Yamada Y","year":"2006","unstructured":"Yamada Y, Rothenberg ME, Cancelas JA (2006): Current concepts on the pathogenesis of the hypereosinophilic syndrome\/chronic eosinophilic leukemia. Transl Oncogenomics 1: 53-63.","journal-title":"Transl Oncogenomics"},{"key":"ref-1535878","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fmed.2017.00216","article-title":"(A Critical Appraisal of) Classification of Hypereosinophilic Disorders","volume":"4","author":"Kahn JE","year":"2017","unstructured":"Kahn JE, Groh M, Lef\u00e8vre G (2017): (A Critical Appraisal of) Classification of Hypereosinophilic Disorders. Front Med (Lausanne) 4: 216.","journal-title":"Front Med (Lausanne)"},{"key":"ref-1535879","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197501000-00001","article-title":"The hypereosinophilic syndrome: Analysis of fourteen cases with review of the literature","volume":"54","author":"Chusid MJ","year":"1975","unstructured":"Chusid MJ, Dale DC, West BC, Wolff SM (1975): The hypereosinophilic syndrome: Analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54: 1-27.","journal-title":"Medicine (Baltimore)"},{"key":"ref-1535880","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1182\/blood-2003-11-3850","article-title":"Familial Eosinophilia: A benign disorder?","volume":"103","author":"Klion AD","year":"2004","unstructured":"Klion AD, Law MA, Riemenschneider W, et al. (2004): Familial Eosinophilia: A benign disorder? Blood 103: 4050-4055.","journal-title":"Blood"},{"key":"ref-1535881","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.04.030"},{"key":"ref-1535882","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.iac.2015.05.003","article-title":"Eosinophilia in infectious diseases","volume":"35","author":"O\u2019Connell EM","year":"2015","unstructured":"O\u2019Connell EM, Nutman TB (2015): Eosinophilia in infectious diseases. Immunol Allergy Clin North Am 35: 493-522.","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref-1535883","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.vetpar.2008.10.063","article-title":"Trichinella diagnostics and control: Mandatory and best practices for ensuring food safety","volume":"159","author":"Gajadhar AA","year":"2009","unstructured":"Gajadhar AA, Pozio E, Gamble HR, et al. (2009): Trichinella diagnostics and control: Mandatory and best practices for ensuring food safety. Vet Parasitol 159: 197-205.","journal-title":"Vet Parasitol"},{"key":"ref-1535884","first-page":"414","article-title":"Clinical & biochemical profile of trichinellosis outbreak in North India","volume":"140","author":"Sharma RK","year":"2014","unstructured":"Sharma RK, Raghavendra N, Mohanty S, et al. (2014): Clinical & biochemical profile of trichinellosis outbreak in North India. Indian J Med Res 140: 414-419.","journal-title":"Indian J Med Res"},{"key":"ref-1535885","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4269\/ajtmh.2012.12-0075","article-title":"Outbreak of human Trichinellosis in Northern California caused by Trichinella Murrelli","volume":"87","author":"Hall RL","year":"2012","unstructured":"Hall RL, Lindsay A, Hammond C, et al. (2012): Outbreak of human Trichinellosis in Northern California caused by Trichinella Murrelli. Am J Trop Med Hyg 87: 297-302.","journal-title":"Am J Trop Med Hyg"},{"key":"ref-1535886","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/QCO.0000000000000482","article-title":"Recent developments in the epidemiology, diagnosis, and treatment of fasciola infection","volume":"31","author":"Webb CM","year":"2018","unstructured":"Webb CM, Cabada MM (2018): Recent developments in the epidemiology, diagnosis, and treatment of fasciola infection. Curr Opin Infect Dis 31: 409-414.","journal-title":"Curr Opin Infect Dis"},{"key":"ref-1535887","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1086\/324668","article-title":"Clinical and immunologic evaluation of 31 patients with acute schistosomiasis mansoni","volume":"185","author":"de Jesus AR","year":"2002","unstructured":"de Jesus AR, Silva A, Santana LB, et al. (2002): Clinical and immunologic evaluation of 31 patients with acute schistosomiasis mansoni. J Infect Dis 185: 98-105.","journal-title":"J Infect Dis"},{"key":"ref-1535888","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3347\/kjp.2018.56.4.385","article-title":"A retrospective analysis on the cystic echinococcosis cases occured in Northeastern Punjab province, Pakistan","volume":"56","author":"Khan A","year":"2018","unstructured":"Khan A, Zahoor S, Ahmed H, et al. (2018): A retrospective analysis on the cystic echinococcosis cases occured in Northeastern Punjab province, Pakistan. Korean J Parasitol 56: 385-390.","journal-title":"Korean J Parasitol"},{"key":"ref-1535889","first-page":"22","article-title":"Cystic Echinococcosis in Central Saudi Arabia: A 5-year experience","volume":"18","author":"Fahim F","year":"2007","unstructured":"Fahim F, Al Salamah SM (2007): Cystic Echinococcosis in Central Saudi Arabia: A 5-year experience. Turk J Gastroenterol 18: 22-27.","journal-title":"Turk J Gastroenterol"},{"key":"ref-1535890","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4269\/ajtmh.14-0445","article-title":"Surgical treatment of multiple hydatid cysts in the liver of a pediatric patient","volume":"92","author":"Lv H","year":"2015","unstructured":"Lv H, Jiang Y, Liu G, et al. (2015): Surgical treatment of multiple hydatid cysts in the liver of a pediatric patient. Am J Trop Med Hyg 92: 595-598.","journal-title":"Am J Trop Med Hyg"},{"key":"ref-1535891","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1086\/338026","article-title":"Diagnostic significance of blood eosinophilia in returning travelers","volume":"34","author":"Schulte C","year":"2002","unstructured":"Schulte C, Krebs B, Jelinek T, et al. (2002): Diagnostic significance of blood eosinophilia in returning travelers. Clin Infect Dis 34: 407-411.","journal-title":"Clin Infect Dis"},{"key":"ref-1535892","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jaip.2018.03.011","article-title":"Eosinophilic pneumonias","volume":"6","author":"Allen J","year":"2018","unstructured":"Allen J, Wert M (2018): Eosinophilic pneumonias. J Allergy Clin Immunol Pract 6: 1455-1461.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref-1535893","doi-asserted-by":"crossref","first-page":"S1487","DOI":"10.1093\/clinids\/11.Supplement_6.S1487","article-title":"Clinical pathologic correlations of Lyme disease","volume":"11","author":"Duray PH","year":"1989","unstructured":"Duray PH (1989): Clinical pathologic correlations of Lyme disease. Rev Infect Dis 11 Suppl 6: S1487-1493.","journal-title":"Rev Infect Dis"},{"key":"ref-1535894","first-page":"92","article-title":"Cerebrospinal fluid eosinophilia in a child with neuroborreliosis","volume":"68","author":"Buda P","year":"2015","unstructured":"Buda P, Zawadka K, Wadowska-K\u0142opotek W, et al. (2015): Cerebrospinal fluid eosinophilia in a child with neuroborreliosis. Wiad Lek 68: 92-94.","journal-title":"Wiad Lek"},{"key":"ref-1535895","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00000372-199610000-00004","article-title":"Borrelial fasciitis: Diffuse fasciitis and peripheral eosinophilia associated with borrelia infection","volume":"18","author":"Granter SR","year":"1996","unstructured":"Granter SR, Barnhill RL, Duray PH (1996): Borrelial fasciitis: Diffuse fasciitis and peripheral eosinophilia associated with borrelia infection. Am J Dermatopathol 18: 465-473.","journal-title":"Am J Dermatopathol"},{"key":"ref-1535896","first-page":"102","article-title":"Persistent marked peripheral eosinophilia due to tuberculosis: A case report","volume":"42","author":"Garg G","year":"2017","unstructured":"Garg G, Gogia A, Kakar A, Miglani P (2017): Persistent marked peripheral eosinophilia due to tuberculosis: A case report. Iran J Med Sci 42: 102-105.","journal-title":"Iran J Med Sci"},{"key":"ref-1535897","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11904-015-0272-x","article-title":"Eosinophilia in patients infected with human immunodeficiency virus","volume":"12","author":"Chou A","year":"2015","unstructured":"Chou A, Serpa JA (2015): Eosinophilia in patients infected with human immunodeficiency virus. Curr HIV\/AIDS Rep 12: 313-316.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref-1535898","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaci.2014.04.005","article-title":"Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma","volume":"134","author":"Newby C","year":"2014","unstructured":"Newby C, Agbetile J, Hargadon B, et al. (2014): Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma. J Allergy Clin Immunol 134: 287-294.","journal-title":"J Allergy Clin Immunol"},{"key":"ref-1535899","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1586\/17476348.2014.880052","article-title":"Biomarkers of eosinophilic inflammation in asthma","volume":"8","author":"Loutsios C","year":"2014","unstructured":"Loutsios C, Farahi N, Porter L, et al. (2014): Biomarkers of eosinophilic inflammation in asthma. Expert Rev Respir Med 8: 143-150.","journal-title":"Expert Rev Respir Med"},{"key":"ref-1535900","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11046-014-9804-y","article-title":"Fungal culture and sensitisation in asthma, cystic fibrosis and chronic obstructive pulmonary disorder: What does it tell us?","volume":"178","author":"Pashley CH","year":"2014","unstructured":"Pashley CH (2014): Fungal culture and sensitisation in asthma, cystic fibrosis and chronic obstructive pulmonary disorder: What does it tell us? Mycopathologia 178: 457-463.","journal-title":"Mycopathologia"},{"key":"ref-1535901","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12016-012-8339-6","article-title":"Clinical spectrum of food allergies: A comprehensive review","volume":"46","author":"Ho MHK","year":"2014","unstructured":"Ho MHK, Wong WHS, Chang C (2014): Clinical spectrum of food allergies: A comprehensive review. Clin Rev Allergy Immunol 46: 225-240.","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref-1535902","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.iac.2014.09.008","article-title":"Atopic dermatitis in children: Clinical features, pathophysiology, and treatment","volume":"35","author":"Lyons JJ","year":"2015","unstructured":"Lyons JJ, Milner JD, Stone KD (2015): Atopic dermatitis in children: Clinical features, pathophysiology, and treatment. Immunol Allergy Clin North Am 35: 161-183.","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref-1535903","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/ijd.14126","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) and multiple organ dysfunction syndrome (MODS): One more reason for a new effective treatment against leishmaniasis","volume":"57","author":"Cuestas D","year":"2018","unstructured":"Cuestas D, Forero Y, Galvis I, et al. (2018): Drug reaction with eosinophilia and systemic symptoms (DRESS) and multiple organ dysfunction syndrome (MODS): One more reason for a new effective treatment against leishmaniasis. Int J Dermatol 57: 1304-1313.","journal-title":"Int J Dermatol"},{"key":"ref-1535904","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS)","volume":"15","author":"Bocquet H","year":"1996","unstructured":"Bocquet H, Bagot M, Roujeau JC (1996): Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg 15: 250-257.","journal-title":"Semin Cutan Med Surg"},{"key":"ref-1535905","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbspin.2013.05.002","article-title":"DRESS syndrome","volume":"81","author":"Descamps V","year":"2014","unstructured":"Descamps V, Ranger-Rogez S (2014): DRESS syndrome. Joint Bone Spine 81: 15-21.","journal-title":"Joint Bone Spine"},{"key":"ref-1535906","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000441280","article-title":"Drug hypersensitivity: How drugs stimulate T cells via pharmacological interaction with immune receptors","volume":"168","author":"Pichler WJ","year":"2015","unstructured":"Pichler WJ, Adam J, Watkins S, et al. (2015): Drug hypersensitivity: How drugs stimulate T cells via pharmacological interaction with immune receptors. Int Arch Allergy Immunol 168: 13-24.","journal-title":"Int Arch Allergy Immunol"},{"key":"ref-1535907","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jaip.2016.11.027","article-title":"Virus reactivation in drug reaction with eosinophilia and systemic symptoms (Dress) results from a strong drug-specific immune response","volume":"5","author":"Roujeau JC","year":"2017","unstructured":"Roujeau JC, Dupin N (2017): Virus reactivation in drug reaction with eosinophilia and systemic symptoms (Dress) results from a strong drug-specific immune response. J Allergy Clin Immunol Pract 5: 811-812.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref-1535908","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.iac.2015.05.001","article-title":"Eosinophilia in rheumatologic\/vascular disorders","volume":"35","author":"Tamaki H","year":"2015","unstructured":"Tamaki H, Chatterjee S, Langford CA (2015): Eosinophilia in rheumatologic\/vascular disorders. Immunol Allergy Clin North Am 35: 453-476.","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref-1535909","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/rheumatology\/kes171","article-title":"Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients","volume":"51","author":"Jakiela B","year":"2012","unstructured":"Jakiela B, Szczeklik W, Plutecka H, et al. (2012): Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients. Rheumatology (Oxford) 51: 1887-1893.","journal-title":"Rheumatology (Oxford)"},{"key":"ref-1535910","doi-asserted-by":"crossref","first-page":"F1769","DOI":"10.1152\/ajprenal.00111.2018","article-title":"Impact of MPO-ANCA-mediated oxidative imbalance on renal vasculitis","volume":"315","author":"Hilhorst M","year":"2018","unstructured":"Hilhorst M, Maria AT, Kavian N, et al. (2018): Impact of MPO-ANCA-mediated oxidative imbalance on renal vasculitis. Am J Physiol Renal Physiol 315: F1769-F1776.","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref-1535911","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1398-9995.2012.02873.x","article-title":"Serum biomarkers are similar in Churg-Strauss syndrome and hypereosinophilic syndrome","volume":"67","author":"Khoury P","year":"2012","unstructured":"Khoury P, Zagallo P, Talar-Williams C, et al. (2012): Serum biomarkers are similar in Churg-Strauss syndrome and hypereosinophilic syndrome. Allergy 67: 1149-1156.","journal-title":"Allergy"},{"key":"ref-1535912","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5114\/ceji.2018.77391","article-title":"IgG4-related disease: Why is it so important?","volume":"43","author":"Legatowicz-Koprowska M","year":"2018","unstructured":"Legatowicz-Koprowska M (2018): IgG4-related disease: Why is it so important? Cent Eur J Immunol 43: 204-208.","journal-title":"Cent Eur J Immunol"},{"key":"ref-1535913","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1002\/art.30514","article-title":"Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan","volume":"63","author":"Allen JA","year":"2011","unstructured":"Allen JA, Peterson A, Sufit R, et al. (2011): Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan. Arthritis Rheum 63: 3633-3639.","journal-title":"Arthritis Rheum"},{"key":"ref-1535914","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.autrev.2014.01.018","article-title":"Eosinophilic myositis: An updated review","volume":"13","author":"Selva-O\u2019Callaghan A","year":"2014","unstructured":"Selva-O\u2019Callaghan A, Trallero-Aragu\u00e1s E, Grau JM (2014): Eosinophilic myositis: An updated review. Autoimmun Rev 13: 375-378.","journal-title":"Autoimmun Rev"},{"key":"ref-1535915","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1182\/blood.V87.4.1416.bloodjournal8741416","article-title":"A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5","volume":"87","author":"Brugnoni D","year":"1996","unstructured":"Brugnoni D, Air\u00f3 P, Rossi G, et al. (1996): A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5. Blood 87: 1416-1422.","journal-title":"Blood"},{"key":"ref-1535916","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.smim.2018.02.001","article-title":"Mast cells, basophils and eosinophils: From allergy to cancer","volume":"35","author":"Rigoni A","year":"2018","unstructured":"Rigoni A, Colombo MP, Pucillo C (2018): Mast cells, basophils and eosinophils: From allergy to cancer. Semin Immunol 35: 29-34.","journal-title":"Semin Immunol"},{"key":"ref-1535917","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/ni.3159","article-title":"Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells","volume":"16","author":"Carretero R","year":"2015","unstructured":"Carretero R, Sektioglu IM, Garbi N, et al. (2015): Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells. Nat Immunol 16: 609-617.","journal-title":"Nat Immunol"},{"key":"ref-1535918","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1038\/ajg.2017.402","article-title":"Peripheral eosinophilia in patients with inflammatory bowel disease defines an aggressive disease phenotype","volume":"112","author":"Click B","year":"2017","unstructured":"Click B, Anderson AM, Koutroubakis IE, et al. (2017): Peripheral eosinophilia in patients with inflammatory bowel disease defines an aggressive disease phenotype. Am J Gastroenterol 112: 1849-1858.","journal-title":"Am J Gastroenterol"},{"key":"ref-1535919","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/bmt.2009.135","article-title":"Eosinophilia predicts better overall survival after acute graft-versus-host-disease","volume":"45","author":"Imahashi N","year":"2010","unstructured":"Imahashi N, Miyamura K, Seto A, et al. (2010): Eosinophilia predicts better overall survival after acute graft-versus-host-disease. Bone Marrow Transplant 45: 371-377.","journal-title":"Bone Marrow Transplant"},{"key":"ref-1535920","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0140-6736(13)61684-0","article-title":"Adrenal insufficiency","volume":"383","author":"Charmandari E","year":"2014","unstructured":"Charmandari E, Nicolaides NC, Chrousos GP (2014): Adrenal insufficiency. Lancet 383: 2152-2167.","journal-title":"Lancet"},{"key":"ref-1535921","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2174\/138945011794751555","article-title":"The molecular mechanisms of glucocorticoids-mediated neutrophil survival","volume":"12","author":"Saffar AS","year":"2011","unstructured":"Saffar AS, Ashdown H, Gounni AS (2011): The molecular mechanisms of glucocorticoids-mediated neutrophil survival. Curr Drug Targets 12: 556-562.","journal-title":"Curr Drug Targets"},{"key":"ref-1535922","doi-asserted-by":"crossref","first-page":"bcr2017223506","DOI":"10.1136\/bcr-2017-223506","article-title":"Unravelling the NERDS syndrome","volume":"2018","author":"Singh AD","year":"2018","unstructured":"Singh AD, Suri TM, Jagdish RK, Kumar U (2018): Unravelling the NERDS syndrome. BMJ Case Rep 2018: bcr2017223506, bcr-2017-223506.","journal-title":"BMJ Case Rep"},{"key":"ref-1535923","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.iac.2006.09.001","article-title":"Cytokine-associated angioedema syndromes including episodic angioedema with eosinophilia (Gleich\u2019s syndrome)","volume":"26","author":"Banerji A","year":"2006","unstructured":"Banerji A, Weller PF, Sheikh J (2006): Cytokine-associated angioedema syndromes including episodic angioedema with eosinophilia (Gleich\u2019s syndrome). Immunol Allergy Clin North Am 26: 769-781.","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref-1535924","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12882-015-0007-7","article-title":"Diagnosis and treatment of a patient with Kimura\u2019s disease associated with nephrotic syndrome and lymphadenopathy of the epitrochlear nodes","volume":"16","author":"Zhu S","year":"2015","unstructured":"Zhu S, Wei P, Chen J, et al. (2015): Diagnosis and treatment of a patient with Kimura\u2019s disease associated with nephrotic syndrome and lymphadenopathy of the epitrochlear nodes. BMC Nephrol 16: 10.","journal-title":"BMC Nephrol"},{"key":"ref-1535925","first-page":"295","article-title":"Kimura\u2019s disease presenting as scrotal mass: A difficult diagnosis","volume":"15","author":"Xie DP","year":"2018","unstructured":"Xie DP, Xu YF, Li MQ (2018): Kimura\u2019s disease presenting as scrotal mass: A difficult diagnosis. Urol J 15: 295-296.","journal-title":"Urol J"},{"key":"ref-1535926","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11899-008-0007-9","article-title":"Primary eosinophilic disorders: A concise review","volume":"3","author":"Pardanani A","year":"2008","unstructured":"Pardanani A, Tefferi A (2008): Primary eosinophilic disorders: A concise review. Curr Hematol Malig Rep 3: 37-43.","journal-title":"Curr Hematol Malig Rep"},{"key":"ref-1535927","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ajh.23193","article-title":"Chronic eosinophilic leukemia-not otherwise specified has a poor prognosis with unresponsiveness to conventional treatment and high risk of acute transformation","volume":"87","author":"Helbig G","year":"2012","unstructured":"Helbig G, Soja A, Bartkowska-Chrobok A, Kyrcz-Krzemie\u0144 S (2012): Chronic eosinophilic leukemia-not otherwise specified has a poor prognosis with unresponsiveness to conventional treatment and high risk of acute transformation. Am J Hematol 87: 643-645.","journal-title":"Am J Hematol"},{"key":"ref-1535928","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber DA","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et al. (2016): The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127: 2391-2405.","journal-title":"Blood"},{"key":"ref-1535929","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/bjh.12963","article-title":"Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities?","volume":"166","author":"Bain BJ","year":"2014","unstructured":"Bain BJ, Ahmad S (2014): Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities? Br J Haematol 166: 809-817.","journal-title":"Br J Haematol"},{"key":"ref-1535930","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00029330-200805020-00001","article-title":"FIP1L1-PDGFRalpha alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib","volume":"121","author":"Wang L","year":"2008","unstructured":"Wang L, Pan Q, Fu J, et al. (2008): FIP1L1-PDGFRalpha alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib. Chin Med J (Engl) 121: 867-873.","journal-title":"Chin Med J (Engl)"},{"key":"ref-1535931","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11899-015-0280-3","article-title":"Tyrosine kinase inhibitors and therapeutic antibodies in advanced eosinophilic disorders and systemic mastocytosis","volume":"10","author":"Gotlib J","year":"2015","unstructured":"Gotlib J (2015): Tyrosine kinase inhibitors and therapeutic antibodies in advanced eosinophilic disorders and systemic mastocytosis. Curr Hematol Malig Rep 10: 351-361.","journal-title":"Curr Hematol Malig Rep"},{"key":"ref-1535932","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4065\/mcp.2009.0503","article-title":"Hypereosinophilic syndrome and clonal eosinophilia: Point-of-care diagnostic algorithm and treatment update","volume":"85","author":"Tefferi A","year":"2010","unstructured":"Tefferi A, Gotlib J, Pardanani A (2010): Hypereosinophilic syndrome and clonal eosinophilia: Point-of-care diagnostic algorithm and treatment update. Mayo Clin Proc 85: 158-164.","journal-title":"Mayo Clin Proc"},{"key":"ref-1535933","first-page":"253","article-title":"Prognostic factors of hypereosinophilic syndrome. Study of 40 cases","volume":"140","author":"Lefebvre C","year":"1989","unstructured":"Lefebvre C, Bletry O, Degoulet P, et al. (1989): Prognostic factors of hypereosinophilic syndrome. Study of 40 cases. Ann Med Interne (Paris) 140: 253-257.","journal-title":"Ann Med Interne (Paris)"}],"container-title":["Central European Journal of Immunology"],"original-title":[],"link":[{"URL":"https:\/\/ceji.termedia.pl\/pdf-182278-129581","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ceji.termedia.pl\/pdf-182278-129581","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:30:56Z","timestamp":1767947456000},"score":1,"resource":{"primary":{"URL":"https:\/\/ceji.termedia.pl\/The-challenge-of-diagnosing-and-classifying-eosinophilia-and-eosinophil-disorders,182278,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"alternative-id":["182278"],"URL":"https:\/\/doi.org\/10.5114\/ceji.2024.136512","relation":{},"ISSN":["1426-3912","1644-4124"],"issn-type":[{"value":"1426-3912","type":"print"},{"value":"1644-4124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,19]]}}}